Invention Grant
- Patent Title: Glucagon administration system and methods
-
Application No.: US15462334Application Date: 2017-03-17
-
Publication No.: US10549037B2Publication Date: 2020-02-04
- Inventor: Mark C. Estes
- Applicant: Bigfoot Biomedical, Inc.
- Applicant Address: US CA Milpitas
- Assignee: Bigfoot Biomedical, Inc.
- Current Assignee: Bigfoot Biomedical, Inc.
- Current Assignee Address: US CA Milpitas
- Agency: Fish & Richardson P.C.
- Main IPC: A61M5/172
- IPC: A61M5/172 ; A61K38/26 ; A61M5/00 ; A61M5/24 ; A61M5/142

Abstract:
Some embodiments a glucagon administration system can provide a suggested glucagon dosage based on one or more particular parameters (e.g., the user's recent blood glucose characteristics, a glucagon sensitivity value of the user, and other parameters). In some circumstances, the glucagon administration system can receive information indicative of the user's blood glucose level and suggest a glucagon dosage that is at least partially dependent upon a previously stored glucagon sensitivity for the user.
Public/Granted literature
- US20170189615A1 GLUCAGON ADMINISTRATION SYSTEM AND METHODS Public/Granted day:2017-07-06
Information query
IPC分类: